Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-438-30.
Published February 12, 2020 · Recall initiated: January 22, 2020
Summary
FDA records drug Class III recall D-0827-2020, published February 12, 2020 and initiated January 22, 2020. Recalling firm: Ascend Laboratories LLC; Status: Terminated; Reported quantity: 4728 bottles; Lot: Lot #: 19140414, Exp 12/2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: low out of specification results for dissolution testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if MINOCYCLINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MINOCYCLINE HYDROCHLORIDE
- Manufacturer
- Ascend Laboratories LLC
- Distributor
- Nationwide in the USA
- Lot
- Lot #: 19140414, Exp 12/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMinocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by:June 17, 2026
- FDAranitidine hydrochloride, USP ,150 mg tablets a) 14-count bottles ( NDC 43063-844-14); b) 30-count bottlesFebruary 12, 2020
- FDAOlmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd.,February 12, 2020
- FDARanitidine Hydrochloride (powder), USP, Rx only, Spectrum Chemical Mfg Corp., a) 1 gram, b) 5 grams, c) 25February 12, 2020
- FDAClonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by: Unichem LaboratoriesFebruary 12, 2020
- FDAABS800 Chemistry Analyzer Part Number BA81F-PA00001, Containing Gas spring YQ-8/18-90-272-180N (Material CodeFebruary 5, 2020
Questions about this recall
Was Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-438-30. recalled?
Yes. FDA published recall D-0827-2020 on February 12, 2020. Reported hazard: Failed Dissolution Specifications: low out of specification results for dissolution testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MINOCYCLINE HYDROCHLORIDE.